CBX8 (12C7) Monoclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-51407M-100uL |
| Product Name | CBX8 (12C7) Monoclonal Antibody |
| Applications |
WB
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | This CBX8 antibody is generated from a mouse immunized with a KLH conjugated synthetic peptide between amino acids from the C-terminal region of human CBX8. |
| Clonality | Monoclonal |
| Clone # | 12C7 |
| Isotype | IgG1 |
| Concentration | Lot Dependent |
| Purification | Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purifie |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C for 12 months. |
| Target | |
| Gene ID | 57332 |
| Swiss Prot | Q9HC52 |
| Synonyms | PC3; RC1; Chromobox protein homolog 8; Polycomb 3 homolog; hPc3; Rectachrome 1; CBX8 |
| Background | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. |
| Application Dilution | |
| WB | 1:300-5000 |
Frequently asked questions
Which applications is CBX8 (12C7) Monoclonal Antibody (bsm-51407M) validated for, and at what dilution?
bsm-51407M is validated for WB (1:300-5000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does CBX8 (12C7) Monoclonal Antibody (bsm-51407M) react with?
Tested reactivity: Human.
How should bsm-51407M be stored?
Store at -20°C for 12 months. Storage buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise CBX8 (12C7) Monoclonal Antibody (bsm-51407M)?
This CBX8 antibody is generated from a mouse immunized with a KLH conjugated synthetic peptide between amino acids from the C-terminal region of human CBX8.